ACET – adicet bio, inc. (US:NASDAQ)

News

Adicet Bio to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026 [Yahoo! Finance]
Adicet Bio to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026
Adicet Bio (NASDAQ:ACET) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Adicet Bio (NASDAQ:ACET) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Adicet Bio Provides Corporate Update and Highlights Expected 2026 Milestones
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com